2626 - 2650 of 9134 Results
Title
Year
-
OPENTitle: Population Prevalence of Deleterious <i>SGCE</i> VariantsJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 10Issue #: 0Start Page: 50End Page: 50Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.567Best OA location URL: http://tremorjournal.org/articles/10.5334/tohm.567/galley/1464/download/Citation Count: 8
-
OPENTitle: Delayed Diagnoses of SGCE Myoclonus-DystoniaJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 10Issue #: 1Start Page: 23End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.334Best OA location URL: http://tremorjournal.org/articles/10.5334/tohm.334/galley/1407/download/Citation Count: 2
- Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates2020OPENTitle: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 5Start Page: 1462End Page: 1475Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa096Best OA location URL: https://academic.oup.com/brain/article-pdf/143/5/1462/33470596/awaa096.pdfCitation Count: 207
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease2017OPENTitle: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 291Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012Best OA location URL: http://www.sciencedirect.com/science/article/pii/S0014488617300213?via%3DihubCitation Count: 25
- Mapping the human brain proteome: opportunities, challenges, and clinical potential2024RESTRICTEDTitle: Mapping the human brain proteome: opportunities, challenges, and clinical potentialJournal Name: Expert Review of ProteomicsPublisher: Informa UK LimitedVol: 21Issue #: 1-3Start Page: 55End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14789450.2024.2313073Citation Count: 3
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 116
- A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's disease2020RESTRICTEDTitle: A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's diseaseJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 77Issue #:Start Page: 238End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2020.04.010Citation Count: 53
-
OPENTitle: Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloidJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page: 217End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s44321-025-00348-7Best OA location URL: https://doi.org/10.1038/s44321-025-00348-7Citation Count: 1
- Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age2020RESTRICTEDTitle: Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and ageJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 198Issue #:Start Page: 101904End Page: 101904Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2020.101904Citation Count: 39
-
OPENTitle: Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 8Start Page: 983End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14089Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14089Citation Count: 5
- Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease2017OPENTitle: Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 12559End Page: 12559Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-12947-7Best OA location URL: https://www.nature.com/articles/s41598-017-12947-7.pdfCitation Count: 25
-
OPENTitle: eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the BrainJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 6162End Page: 6162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-42261-3Best OA location URL: https://www.nature.com/articles/s41598-019-42261-3.pdfCitation Count: 3
-
OPENTitle: Realistic simulation of virtual multi-scale, multi-modal patient trajectories using Bayesian networks and sparse auto-encodersJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 10971End Page: 10971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-67398-4Best OA location URL: https://www.nature.com/articles/s41598-020-67398-4.pdfCitation Count: 13
-
OPENTitle: Inhibition or genetic reduction of ASAH1 /acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson’s patientsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 24Start Page: 2075End Page: 2087Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddaf166Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddaf166/65278149/ddaf166.pdfCitation Count: 1
- ePresentations2024OPENTitle: ePresentationsJournal Name: European Journal of NeurologyPublisher: WileyVol: 31Issue #: S1Start Page: e16338End Page: e16338Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.16338Best OA location URL: https://doi.org/10.1111/ene.16338Citation Count: 0
-
OPENTitle: Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) CohortJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 567End Page: 578Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29329Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29329Citation Count: 114
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 15
-
OPENTitle: Closing the structure-to-function gap for LRRK2Journal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 47Issue #: 3Start Page: 187End Page: 188Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003Best OA location URL: http://www.cell.com/article/S0968000421002243/pdfCitation Count: 9
-
OPENTitle: Lack of Cerebrospinal Fluid α‐Synuclein Seeding in VPS35 D620N ‐ and LRRK2 Y1699C ‐Linked Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 6Start Page: 1605End Page: 1608Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70291Best OA location URL: https://doi.org/10.1002/mds.70291Citation Count: 0
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 61Issue #:Start Page: 102765End Page: 102765Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102765Best OA location URL: https://doi.org/10.1016/j.scr.2022.102765Citation Count: 3
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 8
- Amantadine in the treatment of Parkinson's disease and other movement disorders2021RESTRICTEDTitle: Amantadine in the treatment of Parkinson's disease and other movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1048End Page: 1056Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00249-0Citation Count: 198
-
OPENTitle: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learningJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 3Issue #: 9Start Page: e555End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1Best OA location URL: http://www.thelancet.com/article/S2589750021001011/pdfCitation Count: 90
-
OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Best OA location URL: https://scholarsphere.psu.edu/resources/29554bfc-5d79-4aa6-b1c5-e9441fea8e4aCitation Count: 13